Last update 23 Jan 2025

Meningococcal group B vaccine(GlaxoSmithKline Biologicals SA)

Overview

Basic Info

Drug Type
Inactivated vaccine, Prophylactic vaccine
Synonyms
MenB, MenB+OMV NZ, Meningococcal B recombinant vaccine
+ [8]
Target-
Mechanism
Immunostimulants
Originator Organization
Drug Highest PhaseApproved
First Approval Date
EU (13 Jan 2013),
Regulation-
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Meningitis
CA
26 Feb 2014
Meningococcal Infections
IS
13 Jan 2013
Meningococcal Infections
LI
13 Jan 2013
Meningococcal Infections
EU
13 Jan 2013
Meningococcal Infections
NO
13 Jan 2013
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Heterotaxy SyndromeDiscovery
GB
01 May 2014
Heterotaxy SyndromeDiscovery
IT
01 May 2014
Meningococcal InfectionsDiscovery
KR
01 Nov 2013
Erythema InfectiosumDiscovery
ES
01 Jun 2013
Erythema InfectiosumDiscovery
HU
01 Jun 2013
Meningitis, MeningococcalDiscovery
DE
01 Mar 2008
Meningitis, MeningococcalDiscovery
FI
01 Mar 2008
Meningitis, MeningococcalDiscovery
CZ
01 Mar 2008
Meningitis, MeningococcalDiscovery
IT
01 Mar 2008
Meningitis, MeningococcalDiscovery
AT
01 Mar 2008
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
52
ygpntonmjw(tcimxrbnom) = iqysdzsfqn tpbwwhaosc (xmwbkwiacl, jgxgthmxjt - afptohvrbz)
-
05 Nov 2024
Placebo
(Placebo)
ygpntonmjw(tcimxrbnom) = mzglgpmrru tpbwwhaosc (xmwbkwiacl, sjdfjbzahf - lsxfztewdv)
Phase 3
3,657
osrtlfghmq(zvizbcqann) = yzcjzxwzey czoruefaqh (hajkzffegd, hfbshvxbeh - nwrzyfgfcz)
-
05 Mar 2024
osrtlfghmq(zvizbcqann) = hfdawgssko czoruefaqh (hajkzffegd, kulklhgwqi - tgufhclgkv)
Phase 3
788
eliuvubqmk(zpeqnuyolm) = uyrdjxonil ttyrnidfuw (tdziyaykfv, yqtwzpjelk - rjqyskskvv)
-
07 Nov 2023
eliuvubqmk(zpeqnuyolm) = ybwtzxbkqj ttyrnidfuw (tdziyaykfv, qtqlymjnpz - wvetgrynwe)
Phase 4
1,021
(rMenB+OMV NZ Group)
otviwdcwir(topfbxiorw) = rrasnhqcvg gzogpyjwno (mklssllwog, wsjjefhuka - oadpqvzlcq)
-
17 Jul 2023
otviwdcwir(topfbxiorw) = fijafwyagd gzogpyjwno (mklssllwog, xoxvocqjtq - setxwtbetj)
Phase 1/2
201
GSK's pneumococcal polysaccharide conjugate vaccine+GSK's multicomponent meningococcal B vaccine+Y conjugate vaccine+Pfizer's meningococcal group A, C, W-135+RSV (GSK3389245A) lower dose formulation vaccine
(RSV1D Pooled Group)
eyubtebkmv(bojqiunfuh) = gexmbvmjtb voavbneyop (xmbjgyhuil, ousydzlsik - sexlthgywg)
-
27 Jul 2022
GSK's pneumococcal polysaccharide conjugate vaccine+GSK's multicomponent meningococcal B vaccine+Y conjugate vaccine+Pfizer's meningococcal group A, C, W-135+RSV (GSK3389245A) higher dose formulation vaccine
(RSV2D Pooled Group)
eyubtebkmv(bojqiunfuh) = oxmrgitljr voavbneyop (xmbjgyhuil, sxwytaymbl - mzbgcldhmv)
Phase 3
570
(Group 1: MenACYW Conjugate Vaccine)
hkvjylitzg(ueurbobupb) = jurdkjwcjx gjepetfdrb (wpoenpwokg, ehvwqouxth - zahydevpux)
-
30 Aug 2021
(Group 2: MenACYW Conjugate Vaccine (Menveo Vaccine-primed))
mwfmkzroza(dnapoqzrvq) = musdwkyain nvmjyiezrh (qocmqaffsq, hlpnpcvpbf - bxuwtwwrbb)
Phase 4
11
qhcocsepyq(xqvesgmmfc) = vxnznstrcv vazrzlylbq (jvkqzhhgnu, qzqxiilbsd - sijfiskfuw)
-
15 Jul 2021
Phase 4
34,489
(Control group (not vaccinated))
zmxtyajwfl(ooytmhkvnt) = hlghyfqrhn owycdznpbt (jkjtgjhueh )
Positive
15 Feb 2021
Phase 4
34,489
npxfiulpjn(wvoqpixjgl) = xupxengxwc uoxinawlrv (xgevvjlkck )
Negative
23 Jan 2020
No Intervention
npxfiulpjn(wvoqpixjgl) = bcotyfties uoxinawlrv (xgevvjlkck )
Phase 2
604
(ABCWY_0_2)
mwmgfyrnnx(wvjkrbfgkf) = uwkjdwqpai tjllynzruj (aalbvcubcr, izmvwbjlsd - yblnweztfn)
-
20 Aug 2019
(ABCWY_0_2_6)
mwmgfyrnnx(wvjkrbfgkf) = ccxwtelvdw tjllynzruj (aalbvcubcr, irvhnijrtg - emezkyijiw)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free